Ebihara A, Ohashi K, Ikeda T, Yuhara M, Tagawa H, Yamakado M, Asano Y, Tabei K, Nakazawa K, Kondo K
Department of Clinical Pharmacology, Medical College of Oita, Japan.
Int J Clin Pharmacol Res. 1989;9(1):1-7.
The validity of the Giusti-Hayton method for dosage regimen adjustment in patients with renal impairment was investigated using ranitidine. Five normal healthy volunteers received a single ranitidine recommended dose of 150 mg, and 20 patients with renal disease received single administration in doses individually calculated by the Giusti-Hayton method from each patient's creatinine clearance level, and the various pharmacokinetic parameters were compared. As a result, the area under the time-concentration curve 0----infinity (AUC0----infinity) in the renal disease patients was almost comparable to that in the normal healthy volunteers. The Giusti-Hayton method was considered useful to keep both the AUC0----infinity constant and the mean blood level of the drug in a steady state, in any degree of renal impairment.
采用雷尼替丁研究了Giusti-Hayton方法在肾功能损害患者中调整给药方案的有效性。5名正常健康志愿者接受了150mg雷尼替丁的单次推荐剂量,20名肾病患者接受了根据Giusti-Hayton方法从每位患者的肌酐清除率水平单独计算的剂量的单次给药,并比较了各种药代动力学参数。结果,肾病患者的时间-浓度曲线下面积0至无穷大(AUC0至无穷大)与正常健康志愿者的几乎相当。Giusti-Hayton方法被认为有助于在任何程度的肾功能损害中保持AUC0至无穷大恒定以及药物的平均血药水平处于稳态。